Literature DB >> 16280096

Serum deprivation and re-addition: effects on cyclooxygenase inhibitor sensitivity in cultured glia.

James Phillips1, Brian Pearce.   

Abstract

A number of drugs were assessed for their ability to inhibit stimulus-evoked prostanoid synthesis in cultured glia. These drugs included non-selective cyclooxygenase (COX) inhibitors and those considered to be selective for the inducible isoform of this enzyme (COX-2). Experiments were carried out on normal cultures and those which had been maintained in serum-free growth medium for four days then re-exposed to serum for a further seven days. All of the drugs tested elicited concentration-dependent inhibitions of arachidonic acid (AA)-stimulated thromboxane B(2) (TXB(2)) accumulation in normal cultures with the following rank order of potency: indomethacin > piroxicam > nimesulide = NS398 > ibuprofen >> aspirin > paracetamol. In cultures which had been deprived of serum for four days, basal and AA-stimulated TXB(2) production was considerably reduced, as was the amount of COX immunoreactivity determined by Western blotting. Basal and AA-stimulated TXB(2) production together with COX immunoreactivity were restored to control levels by the re-addition of serum to serum-deprived cultures for 7 days. In these cultures, the rank order of potency was: indomethacin > piroxicam >> ibuprofen > nimesulide = NS398 >> aspirin > paracetamol; however, there were marked charges in the apparent IC(50) values for particular drugs. Indomethacin, piroxicam and aspirin were very similar to control, but the potencies of ibuprofen (3-fold), NS398 (30-fold) and nimesulide (40-fold) were found to be decreased when compared to control. Paracetamol, on the other hand, was found to be almost 3-fold more potent under these conditions. Glia appear to express a COX with a novel sensitivity to particular inhibitors following serum deprivation and re-addition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280096     DOI: 10.1163/156856005774649368

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  34 in total

Review 1.  Cyclooxygenase-2: regulation and relevance in inflammation.

Authors:  J A Mitchell; S Larkin; T J Williams
Journal:  Biochem Pharmacol       Date:  1995-11-09       Impact factor: 5.858

Review 2.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

3.  Characterization of inducible cyclooxygenase in rat brain.

Authors:  C D Breder; D Dewitt; R P Kraig
Journal:  J Comp Neurol       Date:  1995-05-01       Impact factor: 3.215

4.  Phorbol ester stimulation of prostanoid synthesis by cultured astrocytes.

Authors:  J Jeremy; S Murphy; C Morrow; B Pearce; P Dandona
Journal:  Brain Res       Date:  1987-09-01       Impact factor: 3.252

5.  Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia.

Authors:  C Iadecola; C Forster; S Nogawa; H B Clark; M E Ross
Journal:  Acta Neuropathol       Date:  1999-07       Impact factor: 17.088

6.  Expression of cyclooxygenase-2 in astrocytes of human brain after global ischemia.

Authors:  D Maślińska; R Woźniak; A Kaliszek; I Modelska
Journal:  Folia Neuropathol       Date:  1999       Impact factor: 2.038

7.  Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system.

Authors:  W D Hirst; K A Young; R Newton; V C Allport; D R Marriott; G P Wilkin
Journal:  Mol Cell Neurosci       Date:  1999-01       Impact factor: 4.314

8.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Cyclooxygenase-2 is induced globally in infarcted human brain.

Authors:  T Sairanen; A Ristimäki; M L Karjalainen-Lindsberg; A Paetau; M Kaste; P J Lindsberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

Review 10.  Molecular profile of reactive astrocytes--implications for their role in neurologic disease.

Authors:  M Eddleston; L Mucke
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.